GLP-1 medicines are peptides, and the best-studied ones at that

The peptide connection

GLP-1 (glucagon-like peptide-1) is a short peptide hormone your gut releases after you eat. It signals fullness, slows stomach emptying and helps the pancreas release insulin when blood sugar rises. Natural GLP-1 is broken down within minutes.

Semaglutide is a modified version built to last far longer in the body, which allows once-weekly injections. Tirzepatide is a single peptide that activates both the GLP-1 receptor and the receptor for GIP, another gut hormone. Both are peptide medicines in the most literal sense.

What they're approved for

Branded semaglutide (Wegovy) is approved for long-term weight reduction in adults with obesity, or overweight with a weight-related condition, and to reduce the risk of major cardiovascular events in adults with established heart disease and excess weight. It now comes as both an injection and a daily tablet.

Branded tirzepatide is approved, under different brand names, for type 2 diabetes, weight management and obstructive sleep apnea in adults with obesity. These approvals rest on large randomized trials, which is exactly what most wellness peptides lack.

Safety you should know

• Digestive side effects are common, especially when starting or increasing the dose. Doses are usually raised gradually, about every 4 weeks.
• Both carry a boxed warning: they caused thyroid C-cell tumors in rodents. People with a personal or family history of medullary thyroid carcinoma or MEN 2 should not use them.
• Severe, persistent abdominal pain that may spread to the back can signal pancreatitis and needs prompt care.
• Gallbladder problems, dehydration from vomiting or diarrhea and kidney strain are possible.
• They are not for use in pregnancy; semaglutide is typically stopped about 2 months before a planned pregnancy.
• Tirzepatide can reduce the effect of birth control pills, so a backup method is advised for 4 weeks after starting and after each dose increase.

Branded vs. compounded

Trial results apply to the branded products that were studied. Compounded semaglutide and tirzepatide are made by pharmacies, are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. The FDA has received hundreds of adverse event reports involving compounded versions, some linked to dosing errors, and warns against salt forms such as semaglutide sodium and products labeled for research use.

If you use a compounded version, know your exact dose in milligrams and units, follow storage instructions and use the pharmacy's syringe guidance carefully.

Protecting muscle while losing weight

When weight comes off quickly, some of it can be lean tissue rather than fat. In midlife, when muscle is already declining, that matters for strength, balance and metabolism.

The practical defense is resistance training on at least 2 days a week, as the CDC recommends for adults, and enough protein spread across the day. Tracking strength or waist size gives a better picture than the scale alone.

Why the peptide label matters

GLP-1 medicines show what a well-developed peptide drug looks like: a clear mechanism, large trials, known side effects and FDA review. Use them as a benchmark. When a wellness peptide is described in similar terms, ask whether it has the same kind of evidence behind it. Usually it doesn't.

The midlife context

Weight tends to shift toward the middle in midlife. MedlinePlus notes that body fat increases steadily after 30 and tends to collect around the center of the body, while muscle declines. For women, the menopause transition often accelerates this; for men, falling testosterone can contribute.

GLP-1 medicines can be a powerful tool in that setting, especially when excess weight is affecting blood sugar, blood pressure, sleep apnea or joints. They work best alongside protein, strength training and attention to sleep, and with regular check-ins to manage side effects and adjust the dose.

GLP-1 options at HealifyMD

After an online assessment and clinician visit, options may include compounded semaglutide injection (from $299/month, or $550 for 2 months), compounded tirzepatide injection (from $399/month, or $750 for 2 months), compounded oral semaglutide ($299/month) or compounded oral tirzepatide ($399/month). If you use a branded GLP-1 through your own prescription, the Weight Loss Program Membership is from $75/month, or $150 for 3 months. New patients get $100 off the first month of either compounded injection. Prices are confirmed at your eligibility review.